Literature DB >> 16272203

Load-sensitive measures may overestimate global systolic function in the presence of left ventricular hypertrophy: a comparison with load-insensitive measures.

K A Connelly1, D L Prior, D J Kelly, M P Feneley, H Krum, R E Gilbert.   

Abstract

Transgenic animal models have provided a vital insight into the pathogenesis of cardiovascular disease, but functional cardiac assessment is often limited by high heart rates and small heart size. We hypothesized that in the presence of concentric left ventricular (LV) hypertrophy (LVH), load-sensitive measures of contractility may be misinterpreted as overestimating global cardiac function, because the normal function of excess sarcomeres may displace a greater volume of blood during contraction. Conductance catheter technology was used to evaluate pressure-volume (P-V) relationships as a load-insensitive method of assessing cardiac function in vivo in 18-wk-old heterozygous (mRen-2)27 transgenic rats (a model of LVH), compared with age-matched Sprague-Dawley (SD) controls. Anesthetized animals underwent echocardiography followed by P-V loop analysis. Blood pressure, body weight, and heart rate were higher in the Ren-2 rats (P < 0.05). Load-sensitive measures of systolic function, including fractional area change, fractional shortening, ejection fraction, and positive peak rate of LV pressure development, were greater in the Ren-2 than control animals (P < 0.05). Load-insensitive measures of systolic function, including the preload recruitable stroke work relationship and the end-systolic P-V relationship, were not different between Ren-2 and SD rats. Regional wall motion assessed by circumferential shortening velocity suggested enhanced circumferential fiber contractility in the Ren-2 rats (P = 0.02), but tissue Doppler imaging, used to assess longitudinal function, was not different between groups. Although conventional measures suggested enhanced systolic function in the Ren-2 rat, load-insensitive measures of contractility were not different between Ren-2 and SD animals. These findings suggest that the normal range of values for load-sensitive indexes of contractility needs to be altered according to the degree of LVH. To accurately identify changes in systolic function, we suggest that a combination of echocardiography with assessment of load-insensitive measures be used routinely.

Entities:  

Mesh:

Year:  2005        PMID: 16272203     DOI: 10.1152/ajpheart.00577.2005

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  15 in total

Review 1.  The role of echocardiographic deformation imaging in hypertrophic myopathies.

Authors:  Maja Cikes; George R Sutherland; Lisa J Anderson; Bart H Bijnens
Journal:  Nat Rev Cardiol       Date:  2010-05-11       Impact factor: 32.419

2.  Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism.

Authors:  Darren A Yuen; Kim A Connelly; Andrew Advani; Christine Liao; Michael A Kuliszewski; Judy Trogadis; Kerri Thai; Suzanne L Advani; Yuan Zhang; Darren J Kelly; Howard Leong-Poi; Armand Keating; Philip A Marsden; Duncan J Stewart; Richard E Gilbert
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

3.  Comparative analysis of telmisartan and olmesartan on cardiac function in the transgenic (mRen2)27 rat.

Authors:  Vincent G DeMarco; Megan S Johnson; Javad Habibi; Lakshmi Pulakat; Rukhsana Gul; Melvin R Hayden; Roger D Tilmon; Kevin C Dellsperger; Nathaniel Winer; Adam T Whaley-Connell; James R Sowers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-05       Impact factor: 4.733

4.  Inhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in Ren-2 hypertensive rats.

Authors:  Aaron J Trask; Leanne Groban; Brian M Westwood; Jasmina Varagic; Detlev Ganten; Patricia E Gallagher; Mark C Chappell; Carlos M Ferrario
Journal:  Am J Hypertens       Date:  2010-03-18       Impact factor: 2.689

5.  Stroke volume-to-wall stress ratio as a load-adjusted and stiffness-adjusted indicator of ventricular systolic performance in chronic loading.

Authors:  Elie R Chemaly; Antoine H Chaanine; Susumu Sakata; Roger J Hajjar
Journal:  J Appl Physiol (1985)       Date:  2012-08-23

6.  Early outgrowth cells release soluble endocrine antifibrotic factors that reduce progressive organ fibrosis.

Authors:  Darren A Yuen; Kim A Connelly; Yanling Zhang; Suzanne L Advani; Kerri Thai; Golam Kabir; David Kepecs; Christopher Spring; Christopher Smith; Ihor Batruch; Hari Kosanam; Andrew Advani; Eleftherios Diamandis; Philip A Marsden; Richard E Gilbert
Journal:  Stem Cells       Date:  2013-11       Impact factor: 6.277

7.  Insulin restores myocardial presynaptic sympathetic neuronal integrity in insulin-resistant diabetic rats.

Authors:  James T Thackeray; Robert A deKemp; Rob S Beanlands; Jean N DaSilva
Journal:  J Nucl Cardiol       Date:  2013-07-11       Impact factor: 5.952

8.  Chronic Rho-kinase inhibition improves left ventricular contractile dysfunction in early type-1 diabetes by increasing myosin cross-bridge extension.

Authors:  Mark T Waddingham; Amanda J Edgley; Alberto Astolfo; Tadakatsu Inagaki; Yutaka Fujii; Cheng-Kun Du; Dong-Yun Zhan; Hirotsugu Tsuchimochi; Naoto Yagi; Darren J Kelly; Mikiyasu Shirai; James T Pearson
Journal:  Cardiovasc Diabetol       Date:  2015-07-22       Impact factor: 9.951

9.  The role of the Frank-Starling law in the transduction of cellular work to whole organ pump function: a computational modeling analysis.

Authors:  Steven A Niederer; Nicolas P Smith
Journal:  PLoS Comput Biol       Date:  2009-04-24       Impact factor: 4.475

10.  Quantitative study of the effect of tissue microstructure on contraction in a computational model of rat left ventricle.

Authors:  Valentina Carapella; Rafel Bordas; Pras Pathmanathan; Maelene Lohezic; Jurgen E Schneider; Peter Kohl; Kevin Burrage; Vicente Grau
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.